BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 27265457)

  • 1. Protective antibodies against a sphingomyelinase D from Loxosceles intermedia spider venom elicited in mice with different genetic background.
    Oliveira CF; Vilela A; Coura LA; Rodrigues FT; Nagem RA; Chávez-Olortegui C; Maioli TU; Felicori LF
    Vaccine; 2016 Jul; 34(33):3828-34. PubMed ID: 27265457
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recombinant Protein Containing B-Cell Epitopes of Different
    Lima SA; Guerra-Duarte C; Costal-Oliveira F; Mendes TM; Figueiredo LFM; Oliveira D; Machado de Avila RA; Ferrer VP; Trevisan-Silva D; Veiga SS; Minozzo JC; Kalapothakis E; Chávez-Olórtegui C
    Front Immunol; 2018; 9():653. PubMed ID: 29666624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An in vivo protective response against toxic effects of the dermonecrotic protein from Loxosceles intermedia spider venom elicited by synthetic epitopes.
    Felicori L; Fernandes PB; Giusta MS; Duarte CG; Kalapothakis E; Nguyen C; Molina F; Granier C; Chávez-Olórtegui C
    Vaccine; 2009 Jun; 27(31):4201-8. PubMed ID: 19389441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation and molecular characterization of a monoclonal antibody reactive with conserved epitope in sphingomyelinases D from Loxosceles spider venoms.
    Dias-Lopes C; Felicori L; Rubrecht L; Cobo S; Molina L; Nguyen C; Galéa P; Granier C; Molina F; Chávez-Olortegui C
    Vaccine; 2014 Apr; 32(18):2086-92. PubMed ID: 24565754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional characterization and epitope analysis of a recombinant dermonecrotic protein from Loxosceles intermedia spider.
    Felicori L; Araujo SC; de Avila RA; Sanchez EF; Granier C; Kalapothakis E; Chávez-Olórtegui C
    Toxicon; 2006 Oct; 48(5):509-19. PubMed ID: 16934304
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protection against dermonecrotic and lethal activities of Loxosceles intermedia spider venom by immunization with a fused recombinant protein.
    Araujo SC; Castanheira P; Alvarenga LM; Mangili OC; Kalapothakis E; Chávez-Olórtegui C
    Toxicon; 2003 Mar; 41(3):261-7. PubMed ID: 12565747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against the toxic effects of Loxosceles intermedia spider venom elicited by mimotope peptides.
    de Moura J; Felicori L; Moreau V; Guimarães G; Dias-Lopes C; Molina L; Alvarenga LM; Fernandes P; Frézard F; Ribeiro RR; Fleury C; Nguyen C; Molina F; Granier C; Chávez-Olórtegui C
    Vaccine; 2011 Oct; 29(45):7992-8001. PubMed ID: 21872636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cloning and functional characterization of two isoforms of dermonecrotic toxin from Loxosceles intermedia (brown spider) venom gland.
    da Silveira RB; Pigozzo RB; Chaim OM; Appel MH; Dreyfuss JL; Toma L; Mangili OC; Gremski W; Dietrich CP; Nader HB; Veiga SS
    Biochimie; 2006 Sep; 88(9):1241-53. PubMed ID: 16581177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthetic peptides for in vitro evaluation of the neutralizing potency of Loxosceles antivenoms.
    Ramada JS; Becker-Finco A; Minozzo JC; Felicori LF; Machado de Avila RA; Molina F; Nguyen C; de Moura J; Chávez-Olórtegui C; Alvarenga LM
    Toxicon; 2013 Oct; 73():47-55. PubMed ID: 23856101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoprotection elicited in rabbit by a chimeric protein containing B-cell epitopes of Sphingomyelinases D from Loxosceles spp. spiders.
    Souza NA; Dias-Lopes C; Matoso ÍHG; de Oliveira CFB; Chávez-Olortegui CD; Minozzo JC; Felicori LF
    Vaccine; 2018 Nov; 36(48):7324-7330. PubMed ID: 30352745
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation and characterization of a recombinant chimeric protein (rCpLi) consisting of B-cell epitopes of a dermonecrotic protein from Loxosceles intermedia spider venom.
    Mendes TM; Oliveira D; Figueiredo LF; Machado-de-Avila RA; Duarte CG; Dias-Lopes C; Guimarães G; Felicori L; Minozzo JC; Chávez-Olortegui C
    Vaccine; 2013 Jun; 31(25):2749-55. PubMed ID: 23664158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Innovative immunization protocols using chimeric recombinant protein for the production of polyspecific loxoscelic antivenom in horses.
    Figueiredo LF; Dias-Lopes C; Alvarenga LM; Mendes TM; Machado-de-Ávila RA; McCormack J; Minozzo JC; Kalapothakis E; Chávez-Olórtegui C
    Toxicon; 2014 Aug; 86():59-67. PubMed ID: 24878371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-loxoscelic horse serum produced against a recombinant dermonecrotic protein of Brazilian Loxosceles intermedia spider neutralize lethal effects of Loxosceles laeta venom from Peru.
    Duarte CG; Bonilla C; Guimarães G; Machado de Avila RA; Mendes TM; Silva W; Tintaya B; Yarleque A; Chávez-Olórtegui C
    Toxicon; 2015 Jan; 93():37-40. PubMed ID: 25448393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutralization of dermonecrotic and lethal activities and differences among 32-35 kDa toxins of medically important Loxosceles spider venoms in Brazil revealed by monoclonal antibodies.
    Guilherme P; Fernandes I; Barbaro KC
    Toxicon; 2001 Sep; 39(9):1333-42. PubMed ID: 11384721
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular cloning, expression and immunological properties of LiD1, a protein from the dermonecrotic family of Loxosceles intermedia spider venom.
    Kalapothakis E; Araujo SC; de Castro CS; Mendes TM; Gomez MV; Mangili OC; Gubert IC; Chávez-Olórtegui C
    Toxicon; 2002 Dec; 40(12):1691-9. PubMed ID: 12457881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A protective immune response against lethal, dermonecrotic and hemorrhagic effects of Loxosceles intermedia venom elicited by a 27-residue peptide.
    Dias-Lopes C; Guimarães G; Felicori L; Fernandes P; Emery L; Kalapothakis E; Nguyen C; Molina F; Granier C; Chávez-Olórtegui C
    Toxicon; 2010; 55(2-3):481-7. PubMed ID: 19818803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the venom from the Brazilian Brown Spider Loxosceles similis Moenkhaus, 1898 (Araneae, Sicariidae).
    Silvestre FG; de Castro CS; de Moura JF; Giusta MS; De Maria M; Alvares ES; Lobato FC; Assis RA; Gonçalves LA; Gubert IC; Chávez-Olórtegui C; Kalapothakis E
    Toxicon; 2005 Dec; 46(8):927-36. PubMed ID: 16289643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Engineered antigen containing epitopes from Loxosceles spp. spider toxins induces a monoclonal antibody (Lox-mAb3) against astacin-like metalloproteases.
    Costa TGF; Costal-Oliveira F; de Assis TCS; Lima SA; Martins CA; Finco AB; Veiga SS; Soccol VT; Machado-de-Ávila RA; Figueiredo LFM; Minozzo JC; Kalapothakis E; Guerra-Duarte C; Alvarenga LM; Chávez-Olórtegui C
    Int J Biol Macromol; 2020 Nov; 162():490-500. PubMed ID: 32574737
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astacin-like metalloproteases are a gene family of toxins present in the venom of different species of the brown spider (genus Loxosceles).
    Trevisan-Silva D; Gremski LH; Chaim OM; da Silveira RB; Meissner GO; Mangili OC; Barbaro KC; Gremski W; Veiga SS; Senff-Ribeiro A
    Biochimie; 2010 Jan; 92(1):21-32. PubMed ID: 19879318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiotoxic effects of Loxosceles intermedia spider venom and the recombinant venom toxin rLiD1.
    Dias-Lopes C; Felicori L; Guimarães G; Gomes ER; Roman-Campos D; Duarte H; Damasceno D; Martins M; Kalapothakis E; Almeida AP; Granier C; Cruz JS; Guatimosim S; Chávez-Olórtegui C
    Toxicon; 2010 Dec; 56(8):1426-35. PubMed ID: 20826175
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.